Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity
Perik, P. J., Rikhof, B., de Jong, F. A., Verweij, J., Gietema, J. A., van der Graaf, W. T. A.
Published in Annals of oncology (01.02.2008)
Published in Annals of oncology (01.02.2008)
Get full text
Journal Article
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour
Rikhof, B., van Doorn, J., Suurmeijer, A.J.H., Rautenberg, M.W., Groenen, P.J.T.A., Verdijk, M.A.J., Jager, P.L., de Jong, S., Gietema, J.A., van der Graaf, W.T.A.
Published in Annals of oncology (01.09.2009)
Published in Annals of oncology (01.09.2009)
Get full text
Journal Article
Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL
Rikhof, B, van der Graaf, W T A, Meijer, C, Le, P T K, Meersma, G J, de Jong, S, Fletcher, J A, Suurmeijer, A J H
Published in British journal of cancer (04.11.2008)
Published in British journal of cancer (04.11.2008)
Get full text
Journal Article
1140TiP Safe stop IPI-NIVO trial: Early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab
Janssen, J.C., van Dijk, B., de Joode, K., Aarts, M., Van den Berkmortel, F., Blank, C.U., Boers-Sonderen, M., Van Den Eertwegh, F., de Groot, J.W., Jalving, M., Joosse, A., Huismans, A., Kapiteijn, E., Naipal, K.A.T., Piersma, D., Rikhof, B., Vreugdenhil, G., Westgeest, H.M., Mulder, E.E.A.P., Van der Veldt, A.A.M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab - study protocol
Janssen, J C, van Dijk, B, de Joode, K, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, van den Eertwegh, A J M, de Groot, J W B, Jalving, M, de Jonge, M J A, Joosse, A, Kapiteijn, E, Kamphuis-Huismans, A M, Naipal, K A T, Piersma, D, Rikhof, B, Westgeest, H M, Vreugdenhil, G, Oomen-de Hoop, E, Mulder, E E A P, van der Veldt, Astrid A M
Published in BMC cancer (23.05.2024)
Published in BMC cancer (23.05.2024)
Get full text
Journal Article
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases
de Groot, Jan Willem B, Rikhof, Bart, van Doorn, Jaap, Bilo, Henk J G, Alleman, Maarten A, Honkoop, Aafke H, van der Graaf, Winette T A
Published in Endocrine-related cancer (01.12.2007)
Published in Endocrine-related cancer (01.12.2007)
Get full text
Journal Article
FDG-PET as a predicitve marker for primary resistance to imatinib (IM) in patients with gastrointestinal stromal tumors (GIST)
Oosting, S., Den Hollander, M. W., Rikhof, B., Rouw, D. B., De Jong, J. R., Jager, P. L., Brouwers, A. H., Van Der Graaf, W. T., De Vries, E., Gietema, J. A., Reyners, A. K. L.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Insulin-like growth factor (IGF)-II in gastrointestinal stromal tumors (GIST): expression, secretion, and clinical relevance
Rikhof, B., van Doorn, J., Suurmeijer, A., Rautenberg, M., Jager, P., Gietema, J., Meijer, C., de Jong, S., van der Graaf, W.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article